Abstract:BackgroundHepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of downstream genes. MiR-21-3p, a liver-enriched miRNA, and SMAD7, the negative regulator of the TGF-β signaling pathway, likely exert a vital influence on HCC progression.AimsHere, we explore the role of the miR-21-3p-SMAD7/YAP1 axis on HCC pathogenesis.MethodsMiRNA microarray analysis was performed for miRNA screening. The dual-luciferase assay was adopted for target verification. Expression of miRNA and related genes were quantified via qRT-PCR, western blotting, and immunohistochemical staining. Flow cytometry and the transwell migration assay were used to detail cell apoptosis, invasion and metastases. Rat models were established to explore the role of the miR-21-3p-SMAD7/YAP1 axis in hepatocarcinogenesis. Bioinformatics analysis was conducted for exploring genes of clinical significance.ResultsMiR-21-3p levels were found to be significantly elevated in hepatocellular carcinoma and indicate poor overall survival. High miR-21-3p levels were associated with advanced tumor stages (P = 0.029), in particular T staging (P = 0.026). Low SMAD7/high YAP1 levels were confirmed in both HCC and rat models with advanced liver fibrosis and cirrhosis. Besides, SMAD7 was demonstrated to be the direct target of miR-21-3p. The effect of MiR-21-3p on tumor phenotypes and YAP1 upregulation could be partly reversed via the restoration of SMAD7 expression in HCC cell lines. Overexpression of YAP1 after miR-21-3p upregulation promoted expression of nuclear transcription effector connective tissue growth factor. Co-survival analysis indicated that lower miR-21-3p/higher SMAD7 (P = 0.0494) and lower miR-21-3p/lower YAP1 (P = 0.0379) group patients had better overall survival rates. Gene Set Variation Analysis revealed that gene sets related to miR-21-3p and SMAD7 were significantly associated with the TGF-β signaling pathway in HCC.ConclusionMiR-21-3p promotes migration and invasion of HCC cells and upregulation of YAP1 expression via direct inhibition of SMAD7, underscoring a major epigenetic mechanism in the pathogenesis of HCC.

MiR-506 Suppresses Proliferation of Hepatoma Cells Through Targeting YAP Mrna 3′UTR

Up-regulation of Mir-506 Inhibits Cell Growth and Disrupt the Cell Cycle by Targeting YAP in Breast Cancer Cells.

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

MiR-506 Suppresses Liver Cancer Angiogenesis Through Targeting Sphingosine Kinase 1 (SPHK1) Mrna

Hsa‐miR‐132 inhibits proliferation of hepatic carcinoma cells by targeting YAP

MiR-21-3p Promotes Hepatocellular Carcinoma Progression Via SMAD7/YAP1 Regulation

MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27.

MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP.

MiR-506-3p Suppresses Papillary Thyroid Cancer Cells Tumorigenesis by Targeting YAP1.

Mir-590-5p Suppresses Hepatocellular Carcinoma Chemoresistance by Targeting YAP1 Expression.

MiR-660-5p promotes the progression of hepatocellular carcinoma by interaction with YWHAH via PI3K/Akt signaling pathway

Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway

MicroRNA-769-5p Contributes to the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells by Attenuating RYBP

Microrna-519 Suppresses Cell Growth And Invasion By Reducing Hur Levels In Hepatocellular Carcinoma

MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1

MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer

microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA

MiR-520b Suppresses Proliferation of Hepatoma Cells Through Targeting Ten-Eleven Translocation 1 (TET1) Mrna

miR-22-3 p suppresses cell proliferation by regulating SP 1 in hepatocellular carcinoma

Mir-302A Inhibits Human HepG2 and SMMC-7721 Cells Proliferation and Promotes Apoptosis by Targeting MAP3K2 and PBX3.